Vietnam's haematology diagnostics sector is developing rapidly as hospitals and clinical laboratories invest in automated testing, higher-throughput systems and more sophisticated blood analysis.

Industry evidence indicates that the country's market for haematology analysers, reagents and associated consumables could be worth approximately US$35–50 million in 2025, with the potential to reach US$55–75 million by 2030.

While this is an indicative market estimate rather than a separately published Vietnam revenue figure, the direction of travel is clear. Rising diagnostic demand, investment in healthcare infrastructure and increasing automation are creating new opportunities for international manufacturers and suppliers.

From blood counts to advanced haematology

Haematology is one of the foundations of clinical diagnostics.

The Complete Blood Count (CBC) is among the most frequently performed laboratory tests, providing information on red blood cells, white blood cells, haemoglobin, haematocrit and platelets.

These results can help clinicians identify or monitor conditions ranging from anaemia and infection to inflammation, blood cancers and other haematological disorders.

But haematology technology is evolving well beyond the conventional blood count.

Modern automated systems can perform increasingly sophisticated cell differentiation, identify abnormal populations, measure reticulocytes and immature cells and generate flags that indicate when additional investigation may be required.

This is driving demand for increasingly sophisticated analysers across Vietnam's hospital and diagnostic laboratory network.

Automation is transforming the haematology laboratory

One of the strongest industry trends is automation.

High-volume laboratories can process hundreds or thousands of samples each day. Manually loading, analysing and reviewing every sample creates significant demands on laboratory staff.

Modern haematology platforms increasingly automate these workflows.

Samples can be identified through barcodes, loaded automatically, analysed and subjected to predefined rerun or reflex rules when abnormal results are detected.

Advanced systems can also be integrated with slide preparation, staining and digital morphology.

The result is potentially faster turnaround, greater standardisation and reduced manual intervention.

For Vietnam, this is particularly important as diagnostic networks expand and laboratories look for ways to increase capacity without proportionately increasing staffing.

Reagents create a recurring market

The commercial opportunity extends far beyond the analyzer itself.

Every haematology analyzer requires a continuing supply of diluents, lysing reagents, stains, cleaning solutions, controls, calibrators and other consumables.

This creates a recurring-revenue market that grows alongside testing volumes.

Unlike the analyzer, which may remain in a laboratory for many years, reagents and consumables are continuously replenished.

Regional market data reinforces the importance of this segment. Consumables represented the largest product category in the Asia-Pacific haematology diagnostics market in 2024 and are also forecast to be its fastest-growing category through 2030.

For suppliers entering Vietnam, the opportunity is therefore not simply to sell equipment. It is to establish a long-term installed base generating continuing demand for reagents, quality controls, consumables, maintenance and technical support.

Five-part analysers are becoming increasingly important

Vietnam's market ranges from relatively simple three-part differential systems to sophisticated five- and six-part automated analysers.

Three-part systems remain relevant to smaller laboratories where cost, footprint and ease of operation are major considerations.

Higher-volume hospitals and diagnostic laboratories increasingly require more advanced platforms.

Five-part differential systems provide more detailed differentiation of white blood cells, improving the information available to clinicians and reducing the need for additional manual testing.

Grand View Research identifies five-part fully automated haematology analysers as the fastest-growing analyzer category within Asia-Pacific.

This creates a natural progression within the Vietnamese market as laboratories move from basic blood-counting systems towards more advanced diagnostic capabilities.

Blood disorders support continued testing demand

Underlying clinical demand also supports the market.

Anaemia, blood cancers, infections and other haematological conditions all require laboratory investigation and monitoring.

At the same time, CBC testing is routinely used far beyond dedicated haematology departments.

Patients undergoing surgery, cancer treatment, emergency care, chronic-disease management and routine health assessment may all require blood-count testing.

Haematology analysers are therefore embedded across the healthcare system rather than confined to specialist centres.

As access to healthcare expands, the number of tests performed should increase with it.

Hospitals remain central — but commercial laboratories matter

Hospital laboratories represent an important customer base, particularly major public and private hospitals in Hanoi, Ho Chi Minh City and other urban centres.

However, commercial diagnostic laboratories are becoming increasingly important.

Regional forecasts identify commercial service providers as one of the faster-growing end-user groups as healthcare systems outsource or consolidate testing into larger, specialised laboratory networks.

For equipment manufacturers, these high-throughput laboratories represent attractive customers because instrument placements can generate substantial recurring reagent volumes.

Government reference laboratories, blood banks, universities and research institutions provide additional market opportunities.

Technology is increasing the value of each analyzer

The competitive landscape is also changing.

Leading manufacturers are no longer competing solely on how many samples an analyzer can process per hour.

Laboratories increasingly evaluate automation, analytical parameters, workflow integration, reagent consumption, reliability, quality control, software connectivity and total cost per test.

Sysmex, for example, offers systems ranging from compact point-of-care hematology analyzers to fully automated platforms incorporating slide preparation and digital cell morphology.

Mindray similarly offers hematology solutions spanning smaller laboratories through to integrated cellular-analysis lines and automated digital morphology.

These developments illustrate how hematology is converging with the wider laboratory-automation market.

Digital morphology could become the next step

Traditionally, abnormal samples flagged by an analyzer may require a blood smear to be prepared and examined manually under a microscope.

Digital morphology is beginning to change this process.

Automated imaging systems can capture images of blood cells and present them digitally for classification and review.

This potentially allows laboratories to standardise workflows, accelerate sample review and enable specialists to examine images remotely.

Combined with artificial intelligence and image-analysis algorithms, digital morphology could become an increasingly important complement to automated hematology analyzers.

For Vietnam, where specialist expertise may be concentrated in major urban hospitals and laboratories, the ability to share and review images digitally could have particular value.

A competitive international market

Vietnam is already attracting leading international hematology companies.

Market research specifically identifies Sysmex, Abbott and Siemens Healthineers among important players in the country's competitive landscape.

They are joined regionally by companies including Beckman Coulter, Mindray, HORIBA, Nihon Kohden, Bio-Rad and Roche.

Competition therefore extends across high-end automation, mid-range analyzers, compact systems, point-of-care technologies, reagents, controls and laboratory workflow solutions.

Price remains important, particularly outside major tertiary hospitals, but laboratories increasingly have to balance acquisition cost against throughput, reagent cost, reliability, service support and clinical capability.

Opportunity across Vietnam's laboratory ecosystem

The opportunity for suppliers extends across a broad range of products.

Hematology analyzers remain at the centre, but growth creates associated demand for reagents, consumables, controls, calibrators, slide makers and stainers, digital morphology systems, laboratory automation, middleware, quality-control solutions and technical services.

Different customer groups will also require different solutions.

Large tertiary hospitals may prioritise high-throughput automation and advanced clinical parameters. Commercial laboratories may focus on throughput, uptime and cost per test. Provincial facilities may require robust mid-range systems, while smaller laboratories may favour compact and affordable analyzers.

This makes Vietnam a market for multiple technology and price segments rather than a single type of hematology platform.

Building the next generation of diagnostic laboratories

Vietnam's hematology analyzer and reagent sector remains a relatively specialised part of the country's broader diagnostics market, but its recurring reagent model and central role in routine clinical testing make it commercially significant.

Based on regional market benchmarks and Vietnam-specific industry evidence, the market is estimated at approximately US$35–50 million in 2025, with the potential to reach US$55–75 million by 2030 as testing volumes and automation increase.

For manufacturers of hematology analyzers, reagents, controls, automation systems and digital morphology technologies, the opportunity is therefore broader than simply placing more instruments.

It is about helping Vietnam's laboratories process more samples, deliver results faster and extract more clinically useful information from every blood test.

As diagnostic infrastructure develops, hematology will remain one of the essential building blocks of the modern Vietnamese laboratory.